Le Lézard
Classified in: Health, Business
Subjects: TNM, PDT, TDS

Hu-Friedy Introduces HuFriedyGroup as the Dental Division of Cantel


CHICAGO, Feb. 20, 2020 /PRNewswire/ -- Hu-Friedy, the world leader in dental instrument manufacturing and instrument reprocessing workflows, today introduced HuFriedyGroup as the Dental Division of Cantel. This announcement follows an extensive and ongoing integration period that began in October when Cantel officially completed the acquisition of Hu-Friedy.

HuFriedyGroup Logo

As the Dental Division of Cantel, HuFriedyGroup represents the union of brands, products, services, and solutions under one roof, including Crosstex, Accutron, SPSmedical, Palmero Healthcare, J & J Instruments, and Hu-Friedy.

Dental professionals looking to improve clinical outcomes, reduce risk, improve efficiencies, drive compliance, and enhance patient and staff safety can take advantage of the unique solutions offered by this group, including unrivaled premium instrumentation, comprehensive infection prevention services and support, and extensive education and community offerings.

"When we agreed to be acquired by Cantel, we knew it would be important that the identity of our dental division reflect the larger value that we are able to bring to the industry," said Ron Saslow, Chairman, HuFriedyGroup. "We are excited about where we landed and feel that our new name reflects our desire to direct our combined resources and talent to provide more value to our customers and partners, as well as the patients who count on manufacturers, distributors and dental professionals to deliver safe conditions and optimal clinical care."

"In a world that gets more complex every day in terms of compliance and infection prevention, we feel that HuFriedyGroup is uniquely positioned through expertise, focus, and solutions to emerge as an essential global partner in the area of infection prevention solutions," said Ken Serota, President, HuFriedyGroup. "We continue to see breaches and realize the challenges dental practices face in understanding and adapting to compliance standards. We feel we are uniquely suited to provide guidance, education, and solutions in this area. With HuFriedyGroup, we can address critical intersections of performance and protection needs for the modern dental professional, which range from instrumentation to PPE, instrument management solutions, waterline maintenance, and biological and chemical monitoring. We call this approach our Circle of Protection, and we are more than excited about the value it will bring to dentistry."

"Our new name, logo and positioning are reflective of our ability to provide a broader customer experience, but in addition to that, the essence of HuFriedyGroup is based on the simple idea of providing best in practice products, services and education so that our customers and partners can be best in practice as well," said Patrick Bernardi, SVP and Chief Marketing Officer, HuFriedyGroup.

The new HuFriedyGroup brand will be featured at the Chicago Midwinter Meeting, booth #3805. For media inquiries, contact Patrick Bernardi at [email protected] or 773.868.5806.

About HuFriedyGroup:
HuFriedyGroup, the dental division of Cantel, is the global leader in infection prevention, instrument manufacturing, and instrument reprocessing workflows, with over 177 years of collective experience in the dental industry. HuFriedyGroup helps dental professionals be the best in practice by providing a complete circle of protection in the dental suite, bringing world class products, services, education, and communities that result in superior clinician performance, superior clinical outcomes, and safety for clinicians and patients. Headquartered in Chicago, HuFriedyGroup products are distributed in more than 100 countries, and the company maintains offices in Argentina, Germany, Italy, China, Singapore, and Japan.

For further information, visit www.hu-friedy.com.

About Cantel Medical:
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, instruments and instrument reprocessing workflow systems serving the dental industry, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.

For further information, visit the Cantel website at www.cantelmedical.com.

Cautionary Statement Regarding Forward-Looking Statements
This press release may contain "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 and other securities laws. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, estimates, or forecasts about our businesses, the industries in which we operate, and the current beliefs and assumptions of management; they do not relate strictly to historical or current facts. Without limiting the foregoing, words or phrases such as "expect," "anticipate," "goal," "project," "intend," "plan," "believe," "seek," "may," "could," "aspire," and variations of such words and similar expressions generally identify forward-looking statements. In addition, any statements that refer to predictions or projections of our future financial performance, anticipated growth, strategic objectives, performance drivers and trends in our businesses, tax benefits and other characterizations of future events or circumstances are forward-looking statements. Readers are cautioned that these forward-looking statements are only predictions about future events, activities or developments and are subject to numerous risks, uncertainties, and assumptions that are difficult to predict. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. Some of the factors which could cause results to differ from those expressed in any forward-looking statement are set forth under Item 1A, "Risk Factors" of our 2019 Annual Report on Form 10-K. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

SOURCE Hu-Friedy


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

at 00:24
In the news release, Roborock Reports 2023 Full Year Financial Results, issued 28-Mar-2024 by Roborock over PR Newswire, we are advised by the company that in the first bullet point of "Growth across Product Categories", the USD amount should read...

28 mar 2024
Royal Bank of Canada ("RBC") today announced it has completed the acquisition of HSBC Bank Canada ("HSBC Canada"). "Today marks one of the most exciting times of our 155-year history and a pivotal milestone in our long-term growth story as we...

28 mar 2024
The opening ceremony of the Boao Forum for Asia (BFA) Annual Conference 2024 was held in Boao, south China's Hainan Province on Thursday, with China's top legislator Zhao Leji stressing China's economic potential, appealing to international investors...

28 mar 2024
OKX Ventures, the investment arm of leading Web3 technology company OKX, has issued updates for March 29, 2024. OKX Ventures...

28 mar 2024
Curio Legacy Ventures (Curio), a frontrunner in nuclear technology innovation, proudly announces a strategic partnership with Navarro Research and Engineering, Inc. (Navarro). This collaboration signals a significant step forward in advancing nuclear...



News published on and distributed by: